AI-powered women's healthcare
built around hormonal intelligence
Sienna Evans Founder & CEO · info@tryherx.com · tryherx.com
The Problem
02

Women's health is under-measured,
under-interpreted, and under-treated.

25%
Quality of Life Gap

Women spend 25% more of their lives in poor health compared to men.

10 yrs
Endometriosis Delay

Average wait time for an accurate endometriosis diagnosis.

$1T
Annual Opportunity

Closing the women's health gap represents $1 trillion annually by 2040.

01

Efficacy Gap

Diagnostics, treatments, and medications are not fully optimized for female biology.

02

Data Gap

Cycle-linked symptoms are tracked casually, but never interpreted clinically.

03

Care Delivery Gap

Women's care is fragmented across apps, providers, pharmacies, and specialists.

Our Solution
04
HERx does not improve the old model.

HERx replaces it.
The Old Model The HERx Model
ReactiveTreats symptoms after they appear → PredictiveAnticipates needs before they escalate
EpisodicCare only at appointments → Continuous24/7 monitoring and guidance
Clinic-basedRequires physical presence → Mobile-firstCare wherever women are
FragmentedDisconnected providers → IntegratedOne ecosystem, one health record
GeneralizedPopulation-level protocols → PersonalizedIndividual cycle and health data
The Platform

Agentic AI that doesn't just inform — it takes action.

01

Dashboard

AI-powered overview with personalized insights and actionable recommendations.

02

Cycle Intelligence

Advanced cycle tracking with hormone insights and AI recommendations.

03

AI Action Center

Agentic AI detects needs and automatically initiates care on your behalf.

04

Prescription & Delivery

Seamless end-to-end care from prescription approval to discreet delivery.

05

Treatment Plan

Personalized protocols with progress tracking and AI-driven adjustments.

Personalized for you AI that acts Clinician-led Integrated care Privacy first
Market Size
07

A massive, underserved, and rapidly growing global market.

CAGR 16.4%
$39B → $97B

Global FemTech

CAGR 25.2%
$↑

Global Telehealth

CAGR 20.5%
$↑

Women's Digital Health

CAGR 12.4%
$↑

GLP-1 / Weight-Loss Rx

Caribbean & Bahamas Beachhead

  • ~4.5M population across Caribbean island nations
  • Underserved by specialized women's health providers
  • High smartphone penetration; WhatsApp-native communication
  • HERx enters as first integrated women's health platform in the region
Early Traction
08

From Waitlist to Revenue: HERx Is Already in Market

50+
Active GLP-1 Beta Patients

Bahamas Pilot

$239K
Addressable ARR

50 patients × $399/mo × 12

20,000
Waitlist Signups

Pre-launch demand

77%
Gross Margin

$309 gross profit / patient

Proven GLP-1 Demand

50+ patients already on GLP-1 programs through HERx in The Bahamas. cycleLogic layers on top of an existing, paying cohort.

Licensed Infrastructure Ready

Active pharmacy licenses, provider agreements, and clinical ops inherited from Day 1. No new licensing required for Phase 1 Bahamas launch.

Highest-LTV Cohort First

At $399/mo, migrating just 30% of existing patients generates $717K ARR before acquiring a single new user.

Competitive Advantage
10

Our moat is operational,
not just technological.

Hardest to Copy

Operational Infrastructure

Active patients, pharmacy, and licensed providers remove the cold-start. Competitors would need 12–18 months and $3M+ to replicate.

Compounds Over Time

Proprietary Health Data

Every interaction trains our models — more users → better predictions → higher retention. A flywheel competitors cannot shortcut.

Zero Competition Today

Caribbean First-Mover

No integrated women's health platform operates in the Caribbean. We secure market share, brand loyalty, and regulatory relationships early.

Business Model
11

Multiple recurring revenue streams —
high-margin from Day 1.

$9.99–$39.99
/ month

Membership

cycleLogic intelligence + app access

$40–$75
/ visit

Telemedicine

Same-day consultations

$399
/ month

GLP-1 Programs

Validated Bahamas rate — already paying

$75–$150
/ month

Hormone Optimization

Recurring subscription

$60–$100
/ session

Mental Health

Therapy access

Custom
B2B

Corporate Wellness

Employer-sponsored plans

Unit Economics
12

Vertical integration drives strong unit economics from early stages.

$399
GLP-1 ARPU/Mo
Validated Bahamas rate
$20–$40
CAC — Bahamas
Via Access Medical base
$80–$150
CAC — Florida
Paid + referral acquisition
10:1+
LTV:CAC Ratio
Target at scale
$4.8K–$9.6K
Estimated LTV
55–70%
Gross Margin Target
20–30%
Net Margin at Scale
Year 4+
Net Margin Timeline
Go-to-Market
13

Simultaneous launch. Disciplined expansion. Global platform.

Phase 1 · Months 1–12

Dual Launch

  • Grow GLP-1 patients in The Bahamas
  • Open FL clinic: 10 physicians + marketing
  • Focus: GLP-1, birth control, cycle tracking
  • Establish ops excellence & unit economics
Phase 2 · Months 12–24

Regional Expansion

  • Expand to Jamaica, Barbados, Trinidad
  • Launch B2B corporate wellness programs
  • Gather diverse data to refine AI models
  • Reach break-even (~900 MAU at $399 ARR)
Phase 3 · Months 24+

U.S. & Global Scale

  • Enter U.S. with a proven, data-backed model
  • Target favorable telehealth states first
  • Leverage B2B2C employer partnerships
  • Series A backed by Caribbean traction
The Team
13

Healthcare expertise meets technology ambition.

Sienna Evans
Founder & CEO

Sienna Evans

Redefining women's healthcare through cycle tracking, telemedicine, and AI-driven insights. With a background in neuroscience and health innovation, she believes women deserve proactive, data-informed care.


Former Miss Bahamas World 2022 and healthcare entrepreneur — founded Access Medical Bahamas, expanding it from a COVID-19 testing lab into a national network of clinics and pharmacies.

Dr. Douglas Smith
Chief Medical Officer

Dr. Douglas Smith

Board-certified OB/GYN (DO, FACOOG) with decades of experience in women's health and patient-centered care. Provides strategic clinical oversight, supports provider partnerships, and shapes a personalized, proactive approach to hormonal health and preventive care across the Caribbean.

Dr. T. Eden Taylor
Pharmaceutical Director

Dr. T. Eden Taylor

A dedicated pharmacist based in Nassau, Bahamas, passionate about advancing women's health through accessible, evidence-based care. Bridges the gap between pharmacy and preventive care to create personalized, supportive healthcare experiences for women.

MD-led Clinical Team Active Pharmacy Operations Caribbean Infrastructure Built Zero Cold-Start Risk
Financials
15

Path to $55M ARR built on validated market rates.

~$1M
Year 1
~$4M
Year 2
~$12M
Year 3
~$28M
Year 4
$55M
Year 5
Month 18
Break-Even Point

Achieved at ~900 active monthly users

55–70%
Gross Margins

Blended across pharmacy and clinical services

$55.0M
Year 5 Target ARR

Driven by U.S. expansion and B2B partnerships

The Ask
16

Fueling the next phase of growth and scale.

$1.5M
Seed Round
40%
Platform Development

AI models, app infrastructure, and EMR integration

30%
Clinical Expansion

Florida clinic launch and specialized provider hiring

20%
Marketing & Acquisition

Patient acquisition campaigns and B2B sales initiatives

10%
Operations & Legal

Regulatory compliance and cross-border logistics

Key Investor Takeaway
17

HERx is not launching from zero.

Revenue-generating clinical demand

50 active GLP-1 Beta patients in The Bahamas, proving immediate willingness to pay for specialized care.

Massive pre-launch demand

20,000 app waitlist signups, demonstrating clear market need and pent-up demand for the platform itself.

Strong unit economics

$309 gross profit per patient per month, operating with an exceptional 77% gross margin from day one.

Immediate expansion potential

If only 5% of the waitlist converts, HERx reaches 500 paying users. At $399/month, this represents $199,500 in monthly revenue and a $2.39M annualized revenue run rate.

The world's first cycle-intelligent telemedicine platform.
$1.5M
Seed Raise
50+
Day 1 Patients
$239K
Addressable ARR
#1
Caribbean Platform
Sienna Evans · Founder & CEO info@tryherx.com · tryherx.com · demo.tryherx.com